2025 - present: University of Muenster, Muenster, Germany, Post doctoral researcher, (Prof. Erich Bornberg-Bauer-Supervisor)
12/2023 to 03/2025: Habib Medical School (IUIU), Kampala, Uganda, Lecturer, (Dr. Awotunde, O. Samson- Supervisor)
09/2019 to 03/2024: Paris Lodron University of Salzburg (PLUS), Salzburg, Austria, Researcher, Prof. Hans Brandstetter (Supervisor)
09/2019 to 12/2023: Paris Lodron University of Salzburg, Salzburg, Austria, Doctoral study program (PhD., Natural & Life Sciences-Biochemistry & Molecular Biology), (Prof. Hans Brandstetter- Supervisor)
07/2017 to 09/2019: Mulago National Referral hospital, Kampala, Uganda, Medical Biochemist, (Nangosa Hamidah- Supervisor)
12/2015 to 07/2017: Habib Medical School (IUIU), Kampala, Uganda, Lecturer, Dr. Awotunde, O. Samson-Supervisor)
09/2012 to 07/2015: Jiangnan University, Wuxi, PR. China, Master's degree study (MSc. Biochemistry and Molecular Biology), (Prof. Ni Ye- Supervisor)
08/2007 to 01/2011: Makerere University, Kampala, Uganda, Bachelor's degree study (BSc. Biochemistry)
Research Interest
De novo protein evolution
Protein engineering
Protein evolution
Structural Biology
Molecular Biology
Biochemistry
Bioinformatics
Grants and Awards
University of Salzburg (NAWI) Publication of the year award 2024 (1st prize winner)
Publications
Jamil Serwanja, Alexander C. Wieland, Astrid Haubenhofer, Hans Brandstetter, and Esther Schönauer, A conserved strategy to attack collagen: The activator domain in bacterial collagenases unwinds triple-helical collagen, PNAS, April 2024 (https://doi.org/10.1073/pnas.2321002121
Jamil Serwanja, Hans Brandstetter and Esther Schoenauer, Quantitative cross-linking via engineered cysteines to study inter-domain interactions in bacterial collagenases, STAR protocols 4, 102519, 2023
Alaa Alhayek, Ahmed S. Abdelsamie, Esther Schönauer, Virgyl Camberlein, Evelyn Hutterer, Gernot Posselt, Jamil Serwanja, Constantin Blöchl, Christian G. Huber, Jörg Haupenthal, Hans Brandstetter, Silja Wessler, and Anna K. H. Hirsch, Discovery and characterization of synthesized and FDA-approved inhibitors of Clostridial and Bacillary collagenases, Journal of medicinal chemistry
Zhang, L. Liu, M. Jamil, S. Han, R. Xu, G. and Ni, Y, PEGylation and pharmacological characterization of a potential anti-tumor drug, an engineered arginine deiminase originated from Pseudomonas plecoglossicida. Cancer Letters 357:346–354
Serwanja, J. Meng-Han, L. Yong-Mei, L. Rui-Zhi, H. Xu, G.C. Ni, Y, Hydrophobic Mutagenesis and Semi-rational Engineering of Arginine Deiminase for Markedly enhanced Stability and Catalytic efficiency, Applied Biochemistry and Biotechnology 176:1335-1350
ORCID: 0000-0001-9927-4025